Bradycardia during dexmedetomidine and therapeutic hypothermia

Journal of Intensive Care Medicine

Volumn 23, Issue 6, 2008, Pages 403-408

  Tobias, Joseph D ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Bradycardia; Dexmedetomidine; Hypothermia; Traumatic brain injury

Indexed keywords

ADRENALIN; DEXMEDETOMIDINE; HYPERTONIC SOLUTION; MANNITOL; NEUROPROTECTIVE AGENT; PROPOFOL; REMIFENTANIL;

AGITATION; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; BRAIN PERFUSION; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSE AXONAL INJURY; DRUG WITHDRAWAL; GLASGOW COMA SCALE; HEART RATE; HEMODYNAMICS; HUMAN; HYPOTENSION; INDUCED HYPOTHERMIA; INTENSIVE CARE; INTRACRANIAL PRESSURE MONITORING; MALE; PRIORITY JOURNAL; SEDATION; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

ACCIDENTS, TRAFFIC; ADRENERGIC ALPHA-AGONISTS; BRADYCARDIA; BRAIN INJURIES; CHILD; CHILD, PRESCHOOL; DEXMEDETOMIDINE; HUMANS; HYPOTHERMIA, INDUCED; INTENSIVE CARE UNITS, PEDIATRIC; INTRACRANIAL PRESSURE; MALE;

EID: 57049084121     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066608324389     Document Type: Article

References (27)

1. Tobias JD Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007 ; 8: 115-131.
2. Talke P., Tong C., Lee HW, et al. Effect of dexmedetomidine on lumbar cerebrospinal fluid pressure in humans. Anesth Analg. 1997 ; 85: 358-364.
3. Zornow MH, Scheller MS, Sheehan PB, et al. Intracranial pressure effects of dexmedetomidine in rabbits. Anesth Analg. 1992 ; 75: 232-237.
4. Karlsson BR, Forsman M., Roald OK, et al. Effect of dexmedetomidine, a selective and potent α2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg. 1990 ; 71: 125-129.
5. Prielipp RC, Wall MH, Tobin JR, et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002 ; 95: 1052-1059.
6. Hoffman WE, Kochs E., Werner C., et al. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the α2-adrenergic antagonist atipamezole. Anesthesiology. 1991 ; 75: 328-332.
7. Kuhmonen J., Pokorny J., Miettinen R., et al. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology. 1997 ; 87: 371-377.
8. Kuhmonen J., Haapalinna A., Sivenius J. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm. 2001 ; 108: 261-271.
9. Laudenbach V., Mantz J., Lagercrantz H., et al. Effects of α2-adrenoceptor agonists on perinatal excitotoxic brain injury. Anesthesiology. 2002 ; 96: 134-141.
10. Engelhard K., Werner C., Kaspar S., et al. Effect of the α2agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology. 2002 ; 96: 450-457.
11. Dahmani S., Rouelle D., Gressens P., et al. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology. 2005 ; 103: 969-977.
12. Berkenbosch JW, Tobias JD Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med. 2003 ; 4: 203-205.
13. Engelhard K., Werner C., Eberspacher E., et al. The effect of α2-adrenergic agonist, dexmedetomidine and the N-methyl-D-aspartate antagonist, S(+) ketamine, on the expression of apoptosis-regulating proteins after incomplete ischemia and reperfusion in rats. Anesth Analg. 2003 ; 96: 524-531.
14. Bloor BC, Ward DS, Belleville JP, et al. Effects of intravenous dexmedetomidine in humans, II: hemodynamic changes. Anesthesiology. 1992 ; 77: 1134-1142.
15. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000 ; 90: 699-705.
16. Aantaa R., Kanto J., Scheinin M., et al. Dexmedetomidine, an alpha2 adrenoreceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology. 1990 ; 73: 230-235.
17. Scheinin H., Aantaa R., Anttila M., et al. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific α2-adrenoreceptor antagonist atipamezole. Anesthesiology. 1998 ; 89: 574-584.
18. Venn RM, Bradshaw CJ, Spencer R., et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999 ; 54: 1136-1142.
19. Peden CJ, Cloote AH, Stratford N., Prys-Roberts C. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia. 2001 ; 56: 408-413.
20. Ruesch S., Levy JH Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery. Anesth Analg. 2002 ; 95: 316-318.
21. Deutsch E., Tobias JD Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia: sevoflurane vs. desflurane. Pediatr Anesth. 2007 ; 17: 438-444.
22. Chrysostomou C., Di Filippo S., Manrique AM, et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med. 2006 ; 7: 126-131.
23. Tobise F., Toyosmima Y., Kawana S. Effect of dexmedetomidine on hemodynamics in pediatric patients following cardiac surgery. Masui. 2007 ; 56: 409-413.
24. Finkel JC, Quezado ZMN. Hypothermia-inudced bradycardia in a neonato receiving dexmedetomidine. J Clin Anesth. 2007 ; 19: 290-292.
25. Lahdesmaki J., Sallinen J., MacDonald E., et al. Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype. Neuropharmacology. 2003 ; 44: 882-892.
26. Quan N., Xin L., Ungar AL, et al. Preoptic norepinephrine-induced hypothermia is mediated by alpha 2-adrenoceptors. Am J Physiol. 1992 ; 262: R407 - R411.
27. Talke P., Tayefeh F., Sessler DI, et al. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology. 1997 ; 87: 835-841.